summari track us perform key
product gener inject surgic care base im sale
overal believ im data point like in-lin
perform across segment would caveat
im analysi focus top product im sale
captur product busi im sale
fluctuat especi short-term believ analysi
use track busi aggreg repres
bax ww sale includ core growth franchis
inject drug biosurgeri see above-averag
growth return potenti rais price target
base updat peer price-to-earnings ebitda valuat
dcf analysi
us gener inject seem track gener in-lin vs
expect base october-novemb actual im sale
estim im sale decemb histor third month
account sale quarter estim us
gener inject im sale clari
figur im sale histor captur one-third
report base us inject sale clari us
sale appli metric estim im sale yield
clari sale ahead
estim said forecast assum drag
puerto rico pr unclear headwind
reflect im sale us gener inject includ cyclo
account ww hospit product revenu total
cyclo sale forecast like ballpark estim
us cyclo sale yr/yr vs extrapol
im sale total yr/yr vs im
sale captur report cyclophosphamid
sale im sale report sale fall captur
report sale vs
figur use analysi extrapol im sale repres
estim seem reason suggest
possibl modest upsid us cyclo account us gener
inject revenu total revenu
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
adjust spin-off baxalta
compani prioriti stock list
compani data secur llc estim reuter
continu previou page
clari im sale growth appear moder public commentari suggest
busi perform well base october-novemb actual im sale extrapol
im sale decemb estim us clari im sale believ im
histor captur clari actual us revenu suggest report clari sale
vs estim base october-novemb im sale data clari us revenu
annual yr/yr total clari im sale ytd estim
primarili due declin levofloxacin sale figur bax recent public commentari
suggest clari perform well even ahead expect simpli ad clari
portfolio bax sale channel continu expect clari accret bax top-lin
growth ebitda margin ep within first year deal close
us surgic appear track larg in-lin expect bax surgic
busi track key anesthesia biosurgeri product base october-novemb
actual im sale extrapol decemb data overal analysi im sale trend suggest
bax us surgic care perform track consist forecast howev would
caveat analysi captur product two busi im sale trend
captur rate im report fluctuat especi short-term
analysi may use direct instead calcul absolut dollar risk us surgic care
anesthesia biosurgeri account ww hospit product revenu nearli total
anesthesia estim im sale total us anesthesia sale
estim histor im sale captur bax us anesthesia sale figur
suggest forecast reason appli im captur rate
estim im sale impli report sale estim us
anesthesia sale due tougher comp compar
biosurgeri estim im sale total repres us biosurgeri sale
forecast histor im sale captur bax us biosurgeri sale figur
also suggest estim reason appli im captur rate
estim im sale impli report sale estim
flattish us biosurgeri sale growth reflect somewhat easier comp similar
improv vs
product totaly/i totaly/i totaly/i chg gener inj sale gener inj sale furosemid bit tart clari gener inj clari gener inj sale im health inc compani report secur llc estimatescyclophosphamid report sales/our im health inc compani report secur llc estim
price target
price target base equal weight ev/ebtida dcf price-to-earnings risk
thesi includ unexpect competit headwind could slow restructur effort signific delay new
believ acceler sale growth expand oper margin consist deliv
reliabl low double-digit ep growth strong balanc sheet could enhanc long-term growth
baxter global medic product compani focus hospit product renal compani
report sale billion ex-fx growth
chgbupivacain hcl lact tart bit hcl sulf im health inc nation sale perspect compani report secur llc estimatesytd jan-sep product totaly/i totaly/i totaly/i chg anesthesia sale anesthesia sale biosurgeri sale biosurgeri sale im health inc compani report secur llc estim medic technolog
